These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
45. Neurochemical variables in delusional depression. Lykouras E; Markianos M; Malliaras D; Stefanis C Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085 [TBL] [Abstract][Full Text] [Related]
46. 4 p.m. baseline cortisol level as a predictor of DST results in depression. Weiler MA; Jobe TH; Nasr SJ; Pandey G; Altman EG J Clin Psychiatry; 1986 Feb; 47(2):60-2. PubMed ID: 3944064 [TBL] [Abstract][Full Text] [Related]
47. Platelet MAO activity in posttraumatic stress disorder. Davidson J; Lipper S; Kilts CD; Mahorney S; Hammett E Am J Psychiatry; 1985 Nov; 142(11):1341-3. PubMed ID: 4061693 [TBL] [Abstract][Full Text] [Related]
48. Personality traits and monoamine oxidase activity in platelets in depressed patients. Perris C; Eisemann M; von Knorring L; Oreland L; Perris H Neuropsychobiology; 1984; 12(4):201-5. PubMed ID: 6535064 [TBL] [Abstract][Full Text] [Related]
49. Cortisol nonsuppression in depression: relationship to clinical variables. Roy A J Affect Disord; 1988; 14(3):265-70. PubMed ID: 2968388 [TBL] [Abstract][Full Text] [Related]
50. What is the clinical significance of an elevated platelet MAO level? Pies RW J Clin Psychopharmacol; 1996 Dec; 16(6):472-3. PubMed ID: 8959484 [No Abstract] [Full Text] [Related]
51. Prediction of postdexamethasone cortisol levels by serum sodium levels in patients with major depression. Tollefson GD; Zander J; Luxenberg M; Saxena S; Godes M; Garvey MJ Am J Psychiatry; 1986 Jan; 143(1):81-4. PubMed ID: 3942292 [TBL] [Abstract][Full Text] [Related]
52. Serum postdexamethasone prolactin measures in depressive patients and control subjects. Maes M; Schotte C; Peeters D; D'Hondt P; Martin M; Blockx P; Minner B; Suy E; Cosyns P J Psychiatr Res; 1991; 25(3):109-16. PubMed ID: 1941707 [TBL] [Abstract][Full Text] [Related]
53. The dexamethasone suppression test with mildly to moderately depressed outpatients. Rabkin JG; Quitkin FM; Stewart JW; McGrath PJ; Puig-Antich J Am J Psychiatry; 1983 Jul; 140(7):926-7. PubMed ID: 6859319 [TBL] [Abstract][Full Text] [Related]
54. Response to dexamethasone in psychotic depression. Caroff S; Winokur A; Rieger W; Schweizer E; Amsterdam J Psychiatry Res; 1983 Jan; 8(1):59-64. PubMed ID: 6572988 [TBL] [Abstract][Full Text] [Related]
55. Platelet MAO-B activity in anxiety and depression. Khan A; Lee E; Dager S; Hyde T; Raisys V; Avery D; Dunner D Biol Psychiatry; 1986 Jul; 21(8-9):847-9. PubMed ID: 3730465 [No Abstract] [Full Text] [Related]
56. Platelet monoamine oxidase activity and clomipramine-induced mania in unipolar depressed patients. van Kammen DP; van Scheyen JD; Murphy DL Biol Psychiatry; 1980 Aug; 15(4):565-73. PubMed ID: 7397287 [TBL] [Abstract][Full Text] [Related]
59. Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Lowy MT; Reder AT; Antel JP; Meltzer HY Am J Psychiatry; 1984 Nov; 141(11):1365-70. PubMed ID: 6333828 [TBL] [Abstract][Full Text] [Related]
60. Monoamine oxidase activity in blood platelets from manic and depressed patients. Takahashi S Folia Psychiatr Neurol Jpn; 1977; 31(1):37-48. PubMed ID: 863345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]